Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
134.75
+0.04 (0.03%)
At close: Aug 20, 2026, 4:00 PM EDT
134.74
-0.01 (-0.01%)
Pre-market: Aug 21, 2026, 7:05 AM EDT
Apogee Therapeutics Employees
Apogee Therapeutics had 261 employees as of December 31, 2025. The number of employees increased by 65 or 33.16% compared to the previous year.
Employees
261
Change (1Y)
65
Growth (1Y)
33.16%
Revenue / Employee
n/a
Profits / Employee
-$1,127,866
Market Cap
10.16B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 261 | 65 | 33.16% |
| Dec 31, 2024 | 196 | 105 | 115.38% |
| Dec 31, 2023 | 91 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bio-Techne | 3,100 |
| Ionis Pharmaceuticals | 1,480 |
| Axsome Therapeutics | 1,346 |
| Cytokinetics | 673 |
| Krystal Biotech | 295 |
| Kymera Therapeutics | 273 |
| Summit Therapeutics | 265 |
| Praxis Precision Medicines | 168 |
APGE News
- 4 days ago - Apogee Therapeutics downgraded to Neutral from Buy at BTIG - TheFly
- 4 days ago - Apogee Therapeutics price target raised to $135 from $81 at Truist - TheFly
- 11 days ago - Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates - GlobeNewsWire
- 11 days ago - Apogee Therapeutics Earnings release: Q2 2026 - Filings
- 11 days ago - Apogee Therapeutics Quarterly report: Q2 2026 - Filings
- 14 days ago - Apogee Therapeutics Proxy statement: Proxy filing - Filings
- 17 days ago - Apogee Therapeutics Proxy statement: Proxy filing - Filings
- 5 weeks ago - Big Pharma's $300 Billion Patent Problem Fuels Biotech Deals - ETF Trends